Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1628301

	registered interest
	date	16/05/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Advanced Therapy Medicinal Products
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of reviewing the way the National Institute for Health and Care Excellence and NHS England evaluate and adopt Advanced Therapy Medicinal Products as technologies with the potential to deliver significant health gains over long periods of time.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	185240
	answer	answer is ministerial correction date of answer 25/05/2023 answer text <p>The National Institute of Health and Care Excellence (NICE) recently carried out a comprehensive review of its methods and processes for health technology evaluation to ensure that they were appropriate to emerging new technologies such as advanced therapeutic medicinal products (ATMPs). NICE published its updated health technology evaluation manual in January 2022 and has introduced a number of changes that ensure that its appraisal processes are suitable for emerging new medicines, including a broader severity modifier and changes to better respond to uncertainty. There are no plans for a further assessment of NICE’s processes for evaluating ATMPs.</p><p> </p><p>NICE’s methods and processes have been proven to be suitable for ATMPs where companies are willing to price their products in a way that represents value to the taxpayer. NICE has recommended 80% of the ATMPs it has evaluated for use by the National Health Service and they are now available for the treatment of NHS patients, including through the Cancer Drugs Fund and managed access agreements negotiated between the NHS and the manufacturer.</p> answering member constituency Colchester answering member printed Will Quince question first answered 25/05/2023 12:35:12 answering member 4423 label Biography information for Will Quince
	tabling member	3960 label Biography information for Henry Smith

1231662

	registered interest
	date	04/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 June 2020 to Question 58767, what plans he has to centrally collate data on the total number of severe asthma patients (a) in England and (b) within each of the NHS E+I regions.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	85020
	answer	answer is ministerial correction date of answer 22/09/2020 answer text <p>There are no plans for this.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 22/09/2020 14:46:46 answering member 4527 label Biography information for Helen Whately
	tabling member	3960 label Biography information for Henry Smith

1231660

	registered interest
	date	04/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 June 2020 to Question 60724, what steps his Department is taking to ensure at-home treatment of severe asthma patients is available and offered to all patients; and what assessment has been made of the clinical capacity released within respiratory units as a result of such home management.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	85018
	answer	answer is ministerial correction date of answer 05/11/2020 answer text <p>Specialist respiratory services for severe asthma, along with urgent and emergency treatment for other serious complaints, have continued throughout the COVID-19 outbreak. In most cases people with severe asthma have been able to receive their medication at home instead of having to attend hospital through increasing home care support and via access to remote outpatient consultations for new patients.</p><p>Although clinical capacity was re-directed to support care of patients with COVID-19 and this need has reduced, trusts are also required to prepare for potential future waves of COVID-19 and this will affect the clinical capacity required particularly in respiratory units. Regions have oversight of the local plans developed by each trust.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 05/11/2020 12:20:51 answering member 4527 label Biography information for Helen Whately
	tabling member	3960 label Biography information for Henry Smith

1231661

	registered interest
	date	04/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 June 2020 to Question 58769, what assessment he has made of the decline to the number of patients accessing biologics therapies for severe asthma in January to March 2020, and what he has to reverse that decline.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	85019
	answer	answer is ministerial correction date of answer 19/10/2020 answer text <p>The National Institute for Health and Care Excellence COVID-19 rapid guideline on severe asthma provides guidance on starting or continuing on biological treatments, for people with severe asthma during the COVID-19 outbreak. The recommendations were written in collaboration with the NHS England Severe Asthma Collaborative. In writing the guidance, particular attention was paid to streamlining the process of moving patients onto biologic therapies to compensate for any possible barriers that may have occurred as a result of changes to the National Health Service, which were made as part of the necessary response to COVID-19.</p><p>Further work is being undertaken by the collaborative to share best practice on providing care to people with severe asthma to ensure on-going provision of high-quality care and to accelerate the initiation of biologics where required.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 19/10/2020 10:33:39 answering member 4527 label Biography information for Helen Whately
	tabling member	3960 label Biography information for Henry Smith

1541365

	registered interest
	date	09/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bereavement Counselling and Mental Health Services: Veterans
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if his Department will take steps to encourage local authorities to include clear signposting for local veteran-specific support services including (a) mental health services and (b) bereavement support.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	83605
	answer	answer is ministerial correction date of answer 18/11/2022 answer text <p>Local authorities are encouraged to receive updates from the National Health Service which outline initiatives in support of the armed forces community, including information on Op COURAGE. Bereavement support is commissioned locally to meet the need of the local population. NHS England has developed guidance for integrated care boards which requires commissioners to ensure there is sufficient access to bereavement support services.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 18/11/2022 11:56:40 answering member 4492 label Biography information for Maria Caulfield
	tabling member	3960 label Biography information for Henry Smith

1232417

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the increased (a) risk and (b) effect of covid-19 on people living with blood cancer.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86632
	answer	answer is ministerial correction date of answer 10/11/2020 answer text <p>Blood cancer patients have a higher chance of severe disease if they contract COVID-19 compared to other cancers, which is why they were placed on the extremely clinically vulnerable list and were advised to shield. During the height of the COVID-19 pandemic, some treatments were delayed when the risk of contracting coronavirus was higher than the risk of delaying treatment.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/11/2020 12:29:21 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1251465

	registered interest
	date	12/11/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 40578, how many people who are on the shielding list and defined as clinically extremely vulnerable with blood cancer are aged (a) 80 and over (b) between 75 and 79 (c) between 70 and 74 (d) between 65 and 69, (e) between 60 and 64 and (f) 59 or younger.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	114831
	answer	answer is ministerial correction date of answer 27/01/2021 answer text <p>The following table shows a count of patients that are classified as being on the Shielded Patient List (SPL) in England with a blood cancer disease group by age band, as at 3 December 2020.</p><table><tbody><tr><td><p>Age Band</p></td><td><p>Patients on the SPL</p></td></tr><tr><td><p>80 years old and over</p></td><td><p>35,298</p></td></tr><tr><td><p>75-79 years old</p></td><td><p>25,773</p></td></tr><tr><td><p>70-74 years old</p></td><td><p>29,676</p></td></tr><tr><td><p>65-69 years old</p></td><td><p>22,680</p></td></tr><tr><td><p>60-64 years old</p></td><td><p>19,084</p></td></tr><tr><td><p>59 years old or younger</p></td><td><p>55,362</p></td></tr></tbody></table><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 27/01/2021 14:50:41 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1232415

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the rising incidence of blood cancer on the funding requirements of NHS services for blood cancer patients.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86631
	answer	answer is ministerial correction date of answer 22/10/2020 answer text <p>The amount spent by the National Health Service on blood cancer-related services is not collected separately to the overall spend on cancer services.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 22/10/2020 13:00:25 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1232418

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of covid-19 on people living with blood cancer being able to make an informed choice on their long-term care and treatment.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86633
	answer	answer is ministerial correction date of answer 10/11/2020 answer text <p>Support and information for all cancer patients, including blood cancer patients, is provided through four personalised care interventions:</p><p>- Personalised care and support planning based on holistic needs assessments;</p><p>- Health and wellbeing information and support, including nutritional advice and psychological support;</p><p>- End of treatment summaries, that provide symptom management information; and</p><p>- A Cancer Care Review with their general practitioner.</p><p>As outlined in the NHS Long Term Plan, these interventions will be implemented in full by 2021.</p><p>During the COVID-19 pandemic, all personalised care and support has continued by telephone, video, online or by post if face to face appointments and group sessions have not been possible.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/11/2020 12:22:35 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1232419

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to introduce a shared decision-making model within the NHS to help meet the complex needs of people living with blood cancers throughout their patient journey.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86634
	answer	answer is ministerial correction date of answer 10/11/2020 answer text <p>The NHS Long Term Plan sets the ambition to offer personalised care to all cancer patients and transform follow-up care, giving people choice and control over the way their care is planned and delivered. This includes ensuring that shared decision-making in care, and personalised care and support planning, are routine for all patients including those with blood cancer.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/11/2020 12:37:17 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith